meglumine antimoniate has been researched along with Exanthema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aouam, K; Boughattas, NA; Brahim, HB; Chaabane, A; Chadli, Z; Chakroun, M; Fredj, NB; Romdhane, HB | 1 |
| Bouassida, S; Boudaya, S; Maalej, N; Masmoudi, A; Mseddi, M; Souissi, A; Turki, H; Zahaf, A | 1 |
2 other study(ies) available for meglumine antimoniate and Exanthema
| Article | Year |
|---|---|
Meglumine antimoniate-induced DRESS: original case with a positive skin test.
Topics: Animals; Antiprotozoal Agents; Cryotherapy; Drug Hypersensitivity Syndrome; Eosinophilia; Exanthema; Female; Humans; Intradermal Tests; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Metronidazole; Middle Aged | 2018 |
[Glucantime injection: benefit versus toxicity].
Topics: Aged; Aged, 80 and over; Antimony; Antiprotozoal Agents; Exanthema; Female; Humans; Injections, Intramuscular; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pain; Retrospective Studies | 2005 |